Author:
SS Kim1, HJ Kim1, GS Shin2
Author address:
1Department of Biomedical Laboratory Science, Daejeon University, Daejeon, Korea
2Department of Life Science, Daejeon University, Daejeon, Korea
Full conference title:
9th Advances Against Aspergillosis
Date: 26 February 2020
Abstract:
Purpose: Aspergillosis is a life-threatening disease in patients with compromised immune systems. Fungal invasion processes are a highly critical step during host cellular infection. Previously, we suggested that Surfactant Protein-D (SP-D) is a protein suppressed by A. fumigatus conidia directly. We investigate what transcription factor and where the promoter region of SP-D is involved in the infection process of conidia-treated cells.
Methods: To investigate the promoter activity of SP-D in fungal infected cells, we cloned the different lengths of the promoter region (-1000 to +1) of SP-D and examined promoter activity in A. fumigatus conidia-treated A549 cells. Then, we assayed the activity of the promoter region of Surfactant Protein-D shows a response to conidia treatment. And then, we predicted what transcription factor is binding and what binding sites in the promoter regions of SP-D was involved using AliBaba 2.1 software. Using decoy assay, we confirmed the transcription factor is bind to the selected region directly.
Results: Previously, we showed that the promoter activity of SP-D is down-regulated to the conidia treatment. Promoter region from -200 to -100 bp of SP-D is the important region to response in the treatment of conidia. We refine the map to elucidate the core region (-150/-126) involved in mediating the conidia-induced SP-D promoter activity. Using AliBaba2.1 software, we select some candidate transcription factors in the promoter region of SP-D that responds to infection of conidia. And, we know the transcription factor HSF1 is located in the response region (-142 to -134 bp). The decoy assay result shows that transcription factor HSF1 is sufficient to decrease the expression of the SP-D gene.
Conclusion: We show that HSF1 as a negative regulator binds the promoter region of SP-D in conidia treated cells. We confirm that HSF1 suppresses the expression of SP-D in conidia-infected cells using decoy assay. We suggest that inhibition of HSF1 binding to the promoter region of SP-D is an important step to inhibit the infection of conidia.
Abstract Number: 34
Link to conference website:
Link Conference abstract:
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
D Luptáková1*, RH Patil1,2, R Dobiáš3,4, DA Stevens5,6, T Pluháček1,2, A Palyzová1, A Škríba1, V Havlíček1,2
2022
23
-
v
Y Bahri*, S Ben.Belgacem, Y Maatouk, A Ben.Salah, M Mastouri
2022
22
-
v
Y Bahri*, S Ben.Belgacem, Y Maatouk, A Ben.Salah, M Mastouri
2022
21
-
v
A Knaz1, A Omrane1, H Chouaieb2, M Chatti2, R Mrassi2, S Ismail2, M Ben Seif2, W Benzarti1, MA Ayed1, A Abdelghani1, A Hayouni1, S Aissa1, I Gargouri1, A Fathallah2*
2022
20
-
v
A Azzabi1, O Mahfoudh1, N Ben Aicha1, W Sahtout1, A Ayadi2, Z Lajmi3, M Smida4, H Chouaieb4, M Chatti4, S Ismail4, R Boukadida1, F Sabri 1, S Ben Amor1, D Zellama1, S Hmissa3, H Kochtali2, A Fathallah4*, Y Guedri1, A Achour1
2022
19
-
v
M Smida1, A Meherzi2, H Chouaieb1, M Chatti1, M Ben Seif1, R Hajlaoui1, M Abdelkefi2, A Fathallah1*
2022
18
-
v
M Sahu1*, M Shah2, MV Rao3, VR Kola4, HK Boorugu5, AR Punjani6, RV Kumar7, S Kumar8, M Manusrut9, RK Rathod10, HK Gonuguntla11, GK Yedlapati12, GR Mallu13, YS Reddy14, RN KomalKumar15, GS Jaishetwar16, KR Balasubramoniam17, SCR Kumar18, B Nagaraju19, PR Sahoo20
2022
17
-
Chronic pulmonary aspergillosis among presumed tuberculosis patients at a tertiary hospital in Ghana
v
BK Ocansey1*, A Adjei2, H Gbadamosi3, C Kosmidis1,4, J Afriyie-Mensah2,5, JO Opintan6, DW Denning1
2022
16
-
v
CD de La Porte1*, CP Provost2, AS Serris1, AC Coste3, MB Bougnoux4, RB Herbrecht5, VB Bru6, FA Ader7, FP Persat8, EC Canet9, FM Morio10, BD Denis11, AA Alanio12, LL Lelièvre13, SC Cassaing14, RS Sonneville15, LM Millon16, OL Lortholary1, ON Naggara2, FL Lanternier1, French Cerebral Mucormycosis Study Group
2022
14